References
- Marchisio P, Baggi E, Bianchini S, et al. Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza. Hum Vaccin Immunother 2012;8:17-20
- Mistry RD, Fischer JB, Prasad PA, et al. Severe complications in influenza-like illnesses. Pediatrics 2014;134:e684-90
- Frank AL, Taber LH, Wells CR, et al. Patterns of shedding of myxoviruses and paramyxoviruses in children. J Infect Dis 1981;144:433-41
- Esposito S, Principi N. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Vaccine 2011;29:7535-41
- Esposito S, Tagliabue C, Tagliaferri L, et al. Preventing influenza in younger children. Clin Microbiol Infect 2012;18(Suppl 5):42-9
- Esposito S, Montinaro V, Bosis S, et al. Recommendations for the use of influenza vaccine in pediatrics. Hum Vaccin Immunother 2012;8:102-6
- Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009;9:185-94
- Esposito S, Montinaro V, Groppali E, et al. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother 2012;8:76-80
- Orsi A, Ansaldi F, de Florentiis D, et al. Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines. Hum Vaccin Immunother 2013;9:582-90
- Centers for Disease Control and Prevention (CDC). Licensure of a high-dose inactivated influenza vaccine for persons aged ≥65 years (Fluzone High-Dose) and guidance for use - United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59:485-6
- Novartis. FLUAD® (MF59®-Adjuvanted Influenza Vaccine) fact sheet. Available form www.novartisvaccines.com/downloads/global-fact-sheets/Fluad_Fact_Sheet_9%278%2714.pdf [Last accessed on 31 January 2015]
- Vesikari T, Pellegrini M, Karvonen A, et al. Enhanced immunogenicity of seasonal influenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J 2009;28:563-71
- Vesikari T, Knuf M, Wutzler P, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011;365:1406-16
- Esposito S, Marchisio P, Ansaldi F, et al. A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months. Vaccine 2010;28:6137-44
- Esposito S, Daleno C, Picciolli I, et al. Immunogenicity and safety of intradermal influenza vaccine in children. Vaccine 2011;29:7606-10
- Esposito S, Bosis S, Morlacchi L, et al. Can infants be protected by means of maternal vaccination? Clin Microbiol Infect 2012;18(Suppl 5):85-92
- Fell DB, Dodds L, MacDonald NE, et al. Influenza vaccination and fetal and neonatal outcomes. Expert Rev Vaccines 2013;12:1417-30
- Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med 2014;371:918-31
- Chu HY, Englund JA. Maternal immunization. Clin Infect Dis 2014;59:560-8
- Ding H, Black CL, Ball S, et al. Influenza vaccination coverage among pregnant women–United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep 2014;63:816-21
- Ernest TB, Elder DP, Martini LG, et al. Developing paediatric medicines: identifying the needs and recognizing the challenges. J Pharm Pharmacol 2007;59:1043-55
- Jang YH, Seong BL. Options and obstacles for designing a universal influenza vaccine. Viruses 2014;6:3159-80